Structural gray and white matter changes in patients with HIV

In this cross-sectional study we used magnetic resonance imaging (MRI)-based voxel based morphometry (VBM) in a sample of HIV positive patients to detect structural gray and white matter changes. Forty-eight HIV positive subjects with (n = 28) or without (n = 20) cognitive deficits (mean age 48.5 ± 9.6 years) and 48 age- and sex-matched HIV negative controls underwent MRI for VBM analyses. Clinical testing in HIV patients included the HIV dementia scale (HDS), Unified Parkinson’s Disease Rating Scale (UPDRS) and the grooved pegboard test. Comparing controls with HIV positive patients with cognitive dysfunction (n = 28) VBM showed gray matter decrease in the anterior cingulate and temporal cortices along with white matter reduction in the midbrain region. These changes were more prominent with increasing cognitive decline, when assigning HIV patients to three cognitive groups (not impaired, mildly impaired, overtly impaired) based on performance in the HIV dementia scale. Regression analysis including all HIV positive patients with available data revealed that prefrontal gray matter atrophy in HIV was associated with longer disease duration (n = 48), while motor dysfunction (n = 48) was associated with basal ganglia gray matter atrophy. Lower CD4 cell count (n = 47) correlated with decrease of occipital gray matter. Our results provide evidence for atrophy of nigro-striatal and fronto-striatal circuits in HIV. This pattern of atrophy is consistent with motor dysfunction and dysexecutive syndrome found in HIV patients with HIV-associated neurocognitive disorder.

[1]  Dinggang Shen,et al.  White matter abnormalities revealed by diffusion tensor imaging in non-demented and demented HIV+ patients , 2009, NeuroImage.

[2]  D. Salmon,et al.  Memory for verbal information in individuals with HIV-associated dementia complex. HNRC Group. , 1997, Journal of clinical and experimental neuropsychology.

[3]  G. D. Pearlson,et al.  Reduced basal ganglia volume in HIV‐1‐associated dementia , 1993, Neurology.

[4]  C. Büchel,et al.  The emergence of explicit memory during learning. , 2010, Cerebral cortex.

[5]  R. Maserati,et al.  Identification of Lymphotropic Polyomavirus in Peripheral Blood from Patients with Leukoencephalopathies and Healthy Individuals , 2009 .

[6]  Chantal E. Stern,et al.  Compromised fronto-striatal functioning in HIV: An fMRI investigation of semantic event sequencing , 2008, Behavioural Brain Research.

[7]  Karl J. Friston,et al.  Voxel-Based Morphometry—The Methods , 2000, NeuroImage.

[8]  D. Richman,et al.  Resting cerebral blood flow , 2009, Neurology.

[9]  G. Arendt,et al.  HIV dementia: the role of the basal ganglia and dopaminergic systems , 2000, Journal of psychopharmacology.

[10]  Karl J. Friston,et al.  A Voxel-Based Morphometric Study of Ageing in 465 Normal Adult Human Brains , 2001, NeuroImage.

[11]  Michael J. Taylor,et al.  Semantic clustering inefficiency in HIV-associated dementia. , 2007, The Journal of neuropsychiatry and clinical neurosciences.

[12]  F. Scaravilli,et al.  Neuropathologic Contributions to Understanding AIDS and the Central Nervous System , 2007, Brain pathology.

[13]  Jean-Marie Annoni,et al.  Cognitive dysfunction in HIV patients despite long-standing suppression of viremia , 2009, AIDS.

[14]  M. Weisbrod,et al.  Maintenance of real objects and their verbal designations in working memory , 2010, Neuroscience Letters.

[15]  I. Grant,et al.  Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. , 2008, Archives of neurology.

[16]  T. Jernigan,et al.  Progressive cerebral volume loss in human immunodeficiency virus infection: a longitudinal volumetric magnetic resonance imaging study. HIV Neurobehavioral Research Center Group. , 1998, Archives of neurology.

[17]  Mahendra Kumar,et al.  Human immunodeficiency virus type 1 RNA Levels in different regions of human brain: Quantification using real-time reverse transcriptase-polymerase chain reaction , 2011, Journal of NeuroVirology.

[18]  Jianhui Zhong,et al.  Effects of Nadir Cd4 Count and Duration of Human Immunodeficiency Virus Infection on Brain Volumes in the Highly Active Antiretroviral Therapy Era , 2022 .

[19]  L. Resnick,et al.  Metabolic asymmetries in asymptomatic HIV-1 seropositive subjects: relationship to disease onset and MRI findings. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  C. Studholme,et al.  Evidence for ongoing brain injury in human immunodeficiency virus-positive patients treated with antiretroviral therapy , 2009, Journal of NeuroVirology.

[21]  B. Brew,et al.  Neuropsychological Functioning and Antiretroviral Treatment in HIV/AIDS: A Review , 2009, Neuropsychology Review.

[22]  S. M. Robinson,et al.  Permeability of the blood–brain barrier to HIV-1 Tat , 2005, Experimental Neurology.

[23]  Chrétien,et al.  Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage , 1999, Neuropathology and applied neurobiology.

[24]  Andreas Hufnagel,et al.  Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART) , 2000, Journal of neurology, neurosurgery, and psychiatry.

[25]  P. Lantos,et al.  Neuronal number and volume alterations in the neocortex of HIV infected individuals. , 1993, Journal of neurology, neurosurgery, and psychiatry.

[26]  N. Tzourio-Mazoyer,et al.  Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain , 2002, NeuroImage.

[27]  Kiralee M. Hayashi,et al.  Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD4+ T lymphocyte decline , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[28]  R. Mitchell Linear increases in BOLD response associated with increasing proportion of incongruent trials across time in a colour Stroop task , 2010, Experimental Brain Research.

[29]  I. Grant,et al.  Verbal fluency in HIV infection: A meta-analytic review , 2006, Journal of the International Neuropsychological Society.

[30]  Linda Chang,et al.  Declined neural efficiency in cognitively stable human immunodeficiency virus patients , 2009, Annals of neurology.

[31]  F. Vaida,et al.  Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy , 2009, Neurology.

[32]  H. Diener,et al.  Substantia nigra hyperechogenicity and CSF dopamine depletion in HIV , 2008, Journal of Neurology.

[33]  I. Grant,et al.  Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders , 2004, Annals of neurology.

[34]  J. Detre,et al.  Caudate blood flow and volume are reduced in HIV+ neurocognitively impaired patients , 2006, Neurology.

[35]  A. Tröster,et al.  Action (verb) generation in HIV-1 infection , 2005, Neuropsychologia.

[36]  O. Selnes,et al.  HIV Dementia Scale: a rapid screening test. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[37]  Hans Jørgen G. Gundersen,et al.  Preferential loss of large neocortical neurons during HIV infection: a study of the size distribution of neocortical neurons in the human brain , 1999, Brain Research.

[38]  Malathi Thothathiri,et al.  Selection for position: The role of left ventrolateral prefrontal cortex in sequencing language , 2010, Brain and Language.

[39]  Maria Flora Salvatori,et al.  Changes in Cognition During Antiretroviral Therapy: Comparison of 2 Different Ranking Systems to Measure Antiretroviral Drug Efficacy on HIV-Associated Neurocognitive Disorders , 2009, Journal of acquired immune deficiency syndromes.

[40]  R. Ownby,et al.  Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains , 2009, Journal of NeuroVirology.

[41]  Paul M. Thompson,et al.  3 D pattern of brain atrophy in HIV / AIDS visualized using tensor-based morphometry , 2006 .